Colts GM Chris Ballard clarifies there was no second PRP injection for WR Alec Pierce’s ankle

Indianapolis Colts general manager Chris Ballard moved to cool a growing injury rumor on Tuesday, clarifying that wide receiver Alec Pierce did not receive a second PRP injection for his rehabbing ankle in late June. The clarification was reported by FOX59/CBS4 broadcaster Mike Chappell after Ballard spoke to covering media in Foxborough, where the Colts were in the early stages of their offseason football calendar.

The dispute centers on a detail that, while technical, carries real meaning for how teams manage soft-tissue recovery and how fans interpret day-to-day injury updates. PRP, or platelet-rich plasma therapy, is sometimes discussed publicly in the context of tendon or other lingering injuries, and any mention of additional injections can quickly become a proxy for whether a player is trending better or is facing setbacks.

In the circulating account Ballard addressed, the claim was that Pierce had undergone a second PRP injection after an earlier treatment, with late June positioned as the timing. Ballard’s clarification, as characterized in the report, pushes back on that timeline and directly contradicts the idea of an additional injection occurring at that point in the process. For Pierce, the difference is less about headlines and more about the story the organization is trying to tell internally: that the rehab plan is following the intended medical path.

The Colts’ interest in tightening the record is also easy to understand from a roster-building standpoint. Pierce is a starting-caliber receiver when healthy and a key part of Indianapolis’ perimeter options. When a player with that role is rehabbing, even minor updates can influence how teams think about workload management, practice availability, and the distribution of targets across the rest of the receiving group.

Ballard’s comment does not, in itself, provide a complete medical prognosis or a timetable for when Pierce will be ready for any specific football activity. It does, however, resolve one specific rumor detail that had taken on momentum online and in conversation among fans. In August, information gaps are often filled quickly, and the Colts appear to have decided it was worth addressing this one directly rather than allowing the misstatement to calcify.

What to watch next is how the Colts continue to handle Pierce’s status in their own day-to-day reporting. If the organization keeps aligning public descriptions with the underlying rehab plan, it becomes easier to separate speculation from confirmed medical decision-making. For Pierce, the next meaningful milestones will be those that are consistently communicated by the team, such as participation levels in practice settings and any official availability designations as the season approaches.